Showing results (391-400 of 533) with videos related to

Sort By:
Pageof 54
Headache|July 27, 2012
Spontaneous behavioral responses in the orofacial region: a model of trigeminal pain in mouseMarcela Romero-Reyes, Simon Akerman, Elaine Nguyen, et al.
Cephalalgia : an International Journal of Headache|April 16, 2019
Efficacy and safety of erenumab (AMG334) in episodic migraine patients with prior preventive treatment failure: A subgroup analysis of a randomized, double-blind, placebo-controlled studyPeter J Goadsby, Koen Paemeleire, Gregor Broessner, et al.
The New England Journal of Medicine|March 12, 2004
Calcitonin gene-related peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraineJes Olesen, Hans-Christoph Diener, Ingo W Husstedt, et al.
Cephalalgia : an International Journal of Headache|February 21, 2025
Efficacy of ubrogepant and atogepant in males and females with migraine: A secondary analysis of randomized clinical trialsPeter J Goadsby, Tim P Jürgens, Elimor Brand-Schieber, et al.
Headache|March 22, 2021
Efficacy of ubrogepant based on prior exposure and response to triptans: A post hoc analysisAndrew M Blumenfeld, Peter J Goadsby, David W Dodick, et al.
Cephalalgia : an International Journal of Headache|September 7, 2011
Immunohistochemical characterization of calcitonin gene-related peptide in the trigeminal system of the familial hemiplegic migraine 1 knock-in mouseRammya Mathew, Anna P Andreou, Linda Chami, et al.
Cephalalgia : an International Journal of Headache|August 14, 2016
Comparative tolerability of treatments for acute migraine: A network meta-analysisKristian Thorlund, Kabirraaj Toor, Ping Wu, et al.
Mayo Clinic Proceedings|October 4, 2011
MAP0004, orally inhaled dihydroergotamine for acute treatment of migraine: efficacy of early and late treatmentsStewart J Tepper, Shashidhar H Kori, Peter J Goadsby, et al.
Lancet (London, England)|July 18, 2019
Efficacy, safety, and tolerability of rimegepant orally disintegrating tablet for the acute treatment of migraine: a randomised, phase 3, double-blind, placebo-controlled trialRobert Croop, Peter J Goadsby, David A Stock, et al.
Headache|July 20, 2018
Identifying Natural Subgroups of Migraine Based on Comorbidity and Concomitant Condition Profiles: Results of the Chronic Migraine Epidemiology and Outcomes (CaMEO) StudyRichard B Lipton, Kristina M Fanning, Dawn C Buse, et al.
Pageof 54